E

EUROAPI

Produces and develops active pharmaceutical ingredients

Overview

EUROAPI produces and supplies active pharmaceutical ingredients (APIs) and provides CDMO services, with a portfolio of about 200 products and a range of technologies. It develops new molecules through its CDMO activities and manufactures APIs by turning raw materials into active ingredients that go into medicines, ensuring quality and regulatory compliance. The company differentiates itself through its broad product range, focus on sustainability, and a mission centered on public health, guided by values of ownership, passion, collaboration, and care. Its goal is to build the future of public health by advancing and securing access to essential active ingredients for medicines worldwide.

Work here?Claim your company

About EUROAPI

Simplify's Rating
Why EUROAPI is rated
C+
Rated B on Competitive Edge
Rated C on Growth Potential
Rated C on Differentiation

Industries

Industrial & ManufacturingHealthcare

Company Size

1,001-5,000

Company Stage

IPO

Headquarters

Paris, France

Founded

2021

Get referred to EUROAPI

See people who can refer or advise you

Simplify Jobs

Simplify's take

What believers are saying

  • 2025 core EBITDA reached €66.2 million, with margin improving to 7.8%.
  • H1 2026 restructuring costs show FOCUS-27 is aggressively shrinking the cost base.
  • July 2025 public aid up to €140 million funds Med4Cure R&D and investment spending.

What critics are saying

  • EUROAPI expects about 10% lower 2026 sales, hit by portfolio rationalization and weaker Sanofi demand.
  • Brindisi is being sold for €5 million while redundancy plans continue in Germany and France.
  • A 2026 France quality dispute and Brindisi litigation can drain cash and management attention.

What makes EUROAPI unique

  • EUROAPI is Europe’s pure-play API maker, focused on regulated fermentation and chemistry.
  • FOCUS-27 and Med4Cure tie the company to European pharmaceutical sovereignty.
  • Sanofi’s lock-up through December 18, 2026 stabilizes the shareholder base during transformation.

Help us improve and share your feedback! Did you find this helpful?

Funding

Total Funding

$496.1M

Above

Industry Average

Funded Over

1 Rounds

Post IPO Debt funding comparison data is currently unavailable. We're working to provide this information soon!
Post IPO Debt Funding Comparison Coming Soon

Stock Price

Growth & Insights

6 month growth

0%

1 year growth

0%

2 year growth

-3%

Recently Posted Jobs

Sign up to get curated job recommendations

EUROAPI is Hiring for 36 Jobs on Simplify!

Find jobs on Simplify and start your career today

Don't see your dream role? Check out thousands of other roles on Simplify.Browse all jobs